Search Results

Drug Shortages

Current Drug Shortages

Drug shortages, discontinued drug shortages, no commercially available drug shortages preparations and resolved drug shortages.

ASHP Drug Shortages

  Toggle navigation

Drug Shortages | AHFS Drug Information

  Toggle navigation

Drug Shortages

Drug Shortages FAQs

What criteria do you use to determine whether something qualifies as a “new shortage?” A drug product shortage is defined as a supply issue that affects how the pharmacy prepares or dispenses a drug product or influences patient care when prescribers must use an alternative agent. (From ASHP’s Guide

Drug Shortages

ASHP Drug Shortages Roundtable Report

Meeting Attendees American Hospital Association American Medical Association American Society of Clinical Oncology American Society of Anesthesiologists American Society of Health-System Pharmacists American Society of Parenteral and Enteral Nutrition Institute for Safe Medication Practices Pew Char

Drug Shortages

Drug Shortages Statistics

National Drug Shortages: New Shortages by Year January 2001 to December 31, 2019      Note: Each column represents the number of new shortages identified during that year. University of Utah Drug Information Service Contact: Erin.Fox@hsc.utah.edu, @foxerinr for more information.   National Drug S

Update on Drug Shortages and New ASHP Resource to Help with Management

 Shopping Cart (0) Log In / Register × Log Out Are you sure you want to log out? Yes No ASHP.ORG | ASHP STORE Menu Home My Learning Activities Catalog Main

Impact of Rising Drug Prices and Drug Shortages on Patients and Hospitals

  Toggle navigation

Professional Development

ASHP Testimony on Increase in Drug Shortages

ASHP testimony to House Energy and Commerce Committee, Subcommittee on Health Hearing: "Examining the Increase in Drug Shortages". Kevin J. Colgan testifies. Duration: 00:04:26 min

Advocacy and Issues

ASHP and Healthcare Groups Urge the Drug Enforcement Administration to Adjust Aggregate Production Quotas to Mitigate Ongoing Drug Shortages

[Submitted via U.S. Mail] Robert W. Patterson Acting Administrator Drug Enforcement Administration 700 Army Navy Drive Arlington, VA 22202 [Submitted electronically to ODLP@usdoj.gov] DEA Diversion Control Division Attn: Liaison and Policy Section 8701 Morrissette Drive Springfield, VA 22152 RE: